Rajeev Garg

Affiliation

MediPrint Ophthalmics

Biography

Dr Garg currently serves as Chief Operating Officer and Member of the Board of Directors for Mediprint Ophthalmic, where he brings a 20-year track record in eyecare leadership, driving groundbreaking innovations from concept to commercialization. He has played a pivotal role in building novel medical device categories at the intersection of medical and consumer markets, elevating industry standards. His contributions include spearheading the development of drug-delivering contact lens portfolios, premium ophthalmology implants, and pediatric myopia management categories from leading ophthalmic companies such as Johnson & Johnson, Bausch & Lomb, & CooperVision. Most recently, he served as Cooper Vision's Global Head of Myopia Management Strategy, leading the strategic vision for the company's myopia management companies and products. Under his guidance, CooperVision's portfolio achieved exceptional growth through strategic M&A activities, establishing new sales channels, and driving category expansion with innovative managed care pathways and novel CMS codes. Prior to this, Dr. Garg served in a Marketing leadership role for many years in the Ophthalmological surgical area as Head of US Surgical Marketing at Bausch & Lomb and Head of Global Marketing at Johnson & Johnson Surgical Vision. In those roles, he successfully launched over 20 ophthalmic implant products, rejuvenated the pipeline, and transformed the marketing landscape for the $1 billion Tecnis brand, solidifying global market share leadership. Beyond his professional endeavors, he served for three years on the Board of the Global Myopia Awareness Coalition, actively driving public awareness of childhood myopia as a disease. Dr Garg’s journey began in the pharmaceutical industry, leading teams across multiple therapeutic areas and culminating in the submission of three New Drug Applications. Dr Garg holds a Ph.D. from Princeton, an MBA from Kellogg, and a Bachelor's degree from IIT Delhi. He resides in Orange County, California, continuing his relentless pursuit of driving innovation and shaping the future of eyecare.